The tightly regulated expression of Brd4 is critical for the maintenance of the cell cycle progression in normal tissues, whereas overexpression or abnormal activation of Brd4 is a significant hallmark of the hyperproliferative cells associated with numerous hematological malignancies and solid tumors [26–28]. Here, BRD4 is linked to hematologic disorder.